Last reviewed · How we verify
NAs monotherapy group
At a glance
| Generic name | NAs monotherapy group |
|---|---|
| Sponsor | Qing XIe |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (A) (PHASE2)
- A Phase III Study to Evaluate the Efficacy and Safety of ZM-H1505R in Patients With CHB (PHASE3)
- Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With Clusters of HBV Infection and Unfavorable Prognosis - A Prospective, Controlled, Multicenter, Cohort Study
- Peginterferon Treatment Study for Inactive Chronic Hepatitis B Patients (PHASE4)
- A Real-World Study of Antiviral Therapy in Children With Chronic Hepatitis B
- Efficacy and Safety of Antiviral Therapy With Peg-interferon for Chronic Hepatitis B Complicated With Nonalcoholic Fatty Liver Disease（OCEAN PROJECT） (PHASE4)
- Pegylated Interferon α in Previously Interferon-treated CHB（Leading Study） (NA)
- A Prospective Study to Evaluate Peginterferon in Reducing the Incidence of HCC in CHB Patients (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |